MD937C2 - Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui - Google Patents

Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui

Info

Publication number
MD937C2
MD937C2 MD94-0311A MD940311A MD937C2 MD 937 C2 MD937 C2 MD 937C2 MD 940311 A MD940311 A MD 940311A MD 937 C2 MD937 C2 MD 937C2
Authority
MD
Moldova
Prior art keywords
physostigmin
skin
administering
therapeutic system
transdermal therapeutic
Prior art date
Application number
MD94-0311A
Other languages
English (en)
Russian (ru)
Other versions
MD940311A (ro
MD937B2 (ro
Inventor
Lothar Deurer
Thomas Hille
Thomas Profitlich
Fritz Stanislaus
Kersten Walter
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh & Co.Kg filed Critical Lts Lohmann Therapie-Systeme Gmbh & Co.Kg
Publication of MD940311A publication Critical patent/MD940311A/ro
Publication of MD937B2 publication Critical patent/MD937B2/xx
Publication of MD937C2 publication Critical patent/MD937C2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Invenţia se referă la sistemul terapeutic transdermic (STT) pentru aplicarea fizostigminei în calitate de component activ, precum şi la procedeul de obţinere a acestuia.Sistem terapeutic transdermic pentru aplicarea cutanată a fizostigminei, care constă dintr-o bază a stratului intermediar adeziv impermeabilă pentru substanţa activă, ce conţine 40...90% de material polimeric şi 0,1...20% bază de fizostigmină sau sărurile ei farmaceutic acceptabile, precum şi dintr-un strat de protecţie ce acoperă stratul intermediar, totodată stratul intermediar conţine material polimeric pe bază de acrilat şi/sau metacrilat şi 0,1...40% de plastifiant cu grupe hidroxil având HLB între 1,1...12,0.Rezultatul tehnic al invenţiei constă în sporirea durabilităţii şi timpului de fixare a STT pe piele şi păstrarea stabilităţii fizostigminei timp îndelungat.
MD94-0311A 1992-11-12 1994-07-26 Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui MD937C2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (3)

Publication Number Publication Date
MD940311A MD940311A (ro) 1998-03-31
MD937B2 MD937B2 (ro) 1998-03-31
MD937C2 true MD937C2 (ro) 1999-01-31

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0311A MD937C2 (ro) 1992-11-12 1994-07-26 Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui

Country Status (32)

Country Link
US (1) US5698216A (ro)
EP (1) EP0667774B1 (ro)
JP (1) JP3407073B2 (ro)
KR (1) KR100254573B1 (ro)
CN (1) CN1088457A (ro)
AT (1) ATE156356T1 (ro)
AU (1) AU684256B2 (ro)
CA (1) CA2147274C (ro)
CZ (1) CZ284008B6 (ro)
DE (2) DE4238223C1 (ro)
DK (1) DK0667774T3 (ro)
EE (1) EE03135B1 (ro)
EG (1) EG20527A (ro)
ES (1) ES2105334T3 (ro)
FI (1) FI952269A0 (ro)
GR (1) GR3024720T3 (ro)
HR (1) HRP931391B1 (ro)
HU (1) HUT72963A (ro)
IL (1) IL107547A (ro)
LT (1) LT3107B (ro)
LV (1) LV10749B (ro)
MD (1) MD937C2 (ro)
MY (1) MY111373A (ro)
NO (1) NO306760B1 (ro)
NZ (1) NZ257136A (ro)
PL (1) PL172999B1 (ro)
RU (1) RU2108812C1 (ro)
SI (1) SI9300589A (ro)
SK (1) SK280185B6 (ro)
WO (1) WO1994010999A1 (ro)
YU (1) YU71293A (ro)
ZA (1) ZA938413B (ro)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) * 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
DE3528979A1 (de) * 1984-08-14 1986-02-27 State Of Israel Represented By The Prime Minister's Office Israel Institute For Biological Research, Ness-Ziona Arzneimittelfreigabesystem
DE3606892A1 (de) * 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3843238C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) * 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
DE3528979A1 (de) * 1984-08-14 1986-02-27 State Of Israel Represented By The Prime Minister's Office Israel Institute For Biological Research, Ness-Ziona Arzneimittelfreigabesystem
DE3606892A1 (de) * 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3843238C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (ro) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine

Also Published As

Publication number Publication date
CN1088457A (zh) 1994-06-29
IL107547A (en) 1996-12-05
CA2147274C (en) 2005-12-13
CZ284008B6 (cs) 1998-07-15
FI952269A (fi) 1995-05-10
IL107547A0 (en) 1994-02-27
ZA938413B (en) 1994-06-09
JP3407073B2 (ja) 2003-05-19
ES2105334T3 (es) 1997-10-16
NO306760B1 (no) 1999-12-20
LV10749A (lv) 1995-08-20
US5698216A (en) 1997-12-16
SK280185B6 (sk) 1999-09-10
AU684256B2 (en) 1997-12-11
HRP931391B1 (en) 1999-12-31
EG20527A (en) 1999-06-30
MY111373A (en) 1999-12-31
KR100254573B1 (ko) 2000-05-01
LTIP1469A (en) 1994-06-15
SI9300589A (en) 1994-06-30
FI952269A0 (fi) 1995-05-10
YU71293A (sh) 1996-07-24
PL308531A1 (en) 1995-08-21
HU9501390D0 (en) 1995-06-28
EP0667774B1 (de) 1997-08-06
JPH08502986A (ja) 1996-04-02
CZ124495A3 (en) 1996-01-17
DE59307089D1 (de) 1997-09-11
EP0667774A1 (de) 1995-08-23
AU5338594A (en) 1994-06-08
EE03135B1 (et) 1998-12-15
NZ257136A (en) 1996-07-26
PL172999B1 (pl) 1998-01-30
NO951864L (no) 1995-05-11
MD940311A (ro) 1998-03-31
HRP931391A2 (en) 1995-02-28
LV10749B (en) 1996-06-20
MD937B2 (ro) 1998-03-31
HUT72963A (en) 1996-06-28
WO1994010999A1 (de) 1994-05-26
CA2147274A1 (en) 1994-05-26
SK59395A3 (en) 1996-05-08
RU2108812C1 (ru) 1998-04-20
KR950703948A (ko) 1995-11-17
LT3107B (en) 1994-12-27
DK0667774T3 (da) 1998-03-23
DE4238223C1 (de) 1994-05-26
ATE156356T1 (de) 1997-08-15
NO951864D0 (no) 1995-05-11
GR3024720T3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
MY109926A (en) Transdermal therapeutic system comprising galanthamine as active component
FI95774C (fi) Menetelmä transdermaalisen, terapeuttisen järjestelmän valmistamiseksi fysostigmiinin annostelemiseksi iholle
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
DE3770836D1 (de) Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20140726